These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

214 related items for PubMed ID: 30390550

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Medical cannabis legalization and opioid prescriptions: evidence on US Medicaid enrollees during 1993-2014.
    Liang D, Bao Y, Wallace M, Grant I, Shi Y.
    Addiction; 2018 Nov; 113(11):2060-2070. PubMed ID: 29989239
    [Abstract] [Full Text] [Related]

  • 3. Impact of Medical Marijuana Legalization on Opioid Use, Chronic Opioid Use, and High-risk Opioid Use.
    Shah A, Hayes CJ, Lakkad M, Martin BC.
    J Gen Intern Med; 2019 Aug; 34(8):1419-1426. PubMed ID: 30684198
    [Abstract] [Full Text] [Related]

  • 4. Recreational marijuana laws and the misuse of prescription opioids: Evidence from National Survey on Drug Use and Health microdata.
    Ali MM, McClellan C, Mutter R, Rees DI.
    Health Econ; 2023 Feb; 32(2):277-301. PubMed ID: 36335085
    [Abstract] [Full Text] [Related]

  • 5. Association of Medical and Adult-Use Marijuana Laws With Opioid Prescribing for Medicaid Enrollees.
    Wen H, Hockenberry JM.
    JAMA Intern Med; 2018 May 01; 178(5):673-679. PubMed ID: 29610827
    [Abstract] [Full Text] [Related]

  • 6. Recreational and Medical Cannabis Legalization and Opioid Prescriptions and Mortality.
    Nguyen HV, McGinty EE, Mital S, Alexander GC.
    JAMA Health Forum; 2024 Jan 05; 5(1):e234897. PubMed ID: 38241056
    [Abstract] [Full Text] [Related]

  • 7. Medical Marijuana Legalization and Opioid- and Pain-Related Outcomes Among Patients Newly Diagnosed With Cancer Receiving Anticancer Treatment.
    Bao Y, Zhang H, Bruera E, Portenoy R, Rosa WE, Reid MC, Wen H.
    JAMA Oncol; 2023 Feb 01; 9(2):206-214. PubMed ID: 36454553
    [Abstract] [Full Text] [Related]

  • 8. United States marijuana legalization and opioid mortality trends before and during the first year of the COVID-19 pandemic.
    Bleyer A, Barnes B, Finn K.
    J Opioid Manag; 2024 Feb 01; 20(2):119-132. PubMed ID: 38700393
    [Abstract] [Full Text] [Related]

  • 9. Drug Legalization and Decriminalization Beliefs Among Substance-using and Nonusing Individuals.
    Hammond AS, Dunn KE, Strain EC.
    J Addict Med; 2020 Feb 01; 14(1):56-62. PubMed ID: 31385846
    [Abstract] [Full Text] [Related]

  • 10. Is marijuana use associated with decreased use of prescription opioids? Toxicological findings from two US national samples of drivers.
    Li G, Chihuri S.
    Subst Abuse Treat Prev Policy; 2020 Feb 17; 15(1):12. PubMed ID: 32066484
    [Abstract] [Full Text] [Related]

  • 11. States With Prescription Drug Monitoring Mandates Saw A Reduction In Opioids Prescribed To Medicaid Enrollees.
    Wen H, Schackman BR, Aden B, Bao Y.
    Health Aff (Millwood); 2017 Apr 01; 36(4):733-741. PubMed ID: 28373340
    [Abstract] [Full Text] [Related]

  • 12. Prescription Opioid Distribution after the Legalization of Recreational Marijuana in Colorado.
    Kropp Lopez AK, Nichols SD, Chung DY, Kaufman DE, McCall KL, Piper BJ.
    Int J Environ Res Public Health; 2020 May 07; 17(9):. PubMed ID: 32392702
    [Abstract] [Full Text] [Related]

  • 13. Association of US Medical Marijuana Laws With Nonmedical Prescription Opioid Use and Prescription Opioid Use Disorder.
    Segura LE, Mauro CM, Levy NS, Khauli N, Philbin MM, Mauro PM, Martins SS.
    JAMA Netw Open; 2019 Jul 03; 2(7):e197216. PubMed ID: 31314118
    [Abstract] [Full Text] [Related]

  • 14. Prescription Opioid Quality Measures Applied Among Pennsylvania Medicaid Enrollees.
    Cochran G, Lo-Ciganic WH, Gellad WF, Gordon AJ, Cole E, Lobo C, Frazier W, Zheng P, Chang CH, Kelley D, Donohue JM.
    J Manag Care Spec Pharm; 2018 Sep 03; 24(9):875-885. PubMed ID: 30156454
    [Abstract] [Full Text] [Related]

  • 15. Controlled Substance Prescribing Patterns--Prescription Behavior Surveillance System, Eight States, 2013.
    Paulozzi LJ, Strickler GK, Kreiner PW, Koris CM, Centers for Disease Control and Prevention (CDC).
    MMWR Surveill Summ; 2015 Oct 16; 64(9):1-14. PubMed ID: 26469747
    [Abstract] [Full Text] [Related]

  • 16. Impact of Marijuana Legalization on Opioid Utilization in Patients Diagnosed with Pain.
    Neilson LM, Swift C, Swart ECS, Huang Y, Parekh N, Munshi KD, Henderson R, Good CB.
    J Gen Intern Med; 2021 Nov 16; 36(11):3417-3422. PubMed ID: 33575906
    [Abstract] [Full Text] [Related]

  • 17. Using prescription monitoring program data to characterize out-of-pocket payments for opioid prescriptions in a state Medicaid program.
    Hartung DM, Ahmed SM, Middleton L, Van Otterloo J, Zhang K, Keast S, Kim H, Johnston K, Deyo RA.
    Pharmacoepidemiol Drug Saf; 2017 Sep 16; 26(9):1053-1060. PubMed ID: 28722211
    [Abstract] [Full Text] [Related]

  • 18. Opioid Analgesics in Georgia Medicaid: Trends in Potential Inappropriate Prescribing Practices by Demographic Characteristics, 2009-2014.
    Jayawardhana J, Abraham AJ, Perri M.
    J Manag Care Spec Pharm; 2018 Sep 16; 24(9):886-894. PubMed ID: 30156455
    [Abstract] [Full Text] [Related]

  • 19. Recreational cannabis legalizations associated with reductions in prescription drug utilization among Medicaid enrollees.
    Raman S, Bradford AC.
    Health Econ; 2022 Jul 16; 31(7):1513-1521. PubMed ID: 35429072
    [Abstract] [Full Text] [Related]

  • 20. Self-Reported Marijuana Use Is Associated with Increased Use of Prescription Opioids Following Traumatic Musculoskeletal Injury.
    Bhashyam AR, Heng M, Harris MB, Vrahas MS, Weaver MJ.
    J Bone Joint Surg Am; 2018 Dec 19; 100(24):2095-2102. PubMed ID: 30562289
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.